A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura.
Giovanni
G
Emilia
Mario
M
Luppi
Monica
M
Morselli
Fabio
F
Forghieri
Leonardo
L
Potenza
Giuseppe
G
Torelli
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001792:Blood Platelets / Q000187:drug effects; D016572:Cyclosporine / Q000008:administration & dosage*; D005260:Female; D006405:Hematology / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*; D012306:Risk; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D016572:Cyclosporine